Breadcrumb

null Institute researcher Maryam Oskoui recognized nationally for pediatric neuromuscular leadership

Muscular Dystrophy Canada honours senior scientist from The Institute with its Healthcare Partner of the Year Award

SOURCE: Montreal Children's Hospital
January 15, 2026

Maryam Oskoui, MD, MSc, senior scientist in the Child Health and Human Development Program at the Research Institute of the McGill University Health Centre (The Institute) and pediatric neurologist at the Montreal Children's Hospital, has received the Healthcare Partner of the Year Award from Muscular Dystrophy Canada. The award is presented as part of the Dr. David Green Recognition Program.

Each year, the Dr. David Green Recognition Program recognizes individuals and teams who go above and beyond to support the neuromuscular community across Canada. The Healthcare Partner of the Year Award recognizes physicians who have demonstrated exceptional achievement in advancing neuromuscular clinical practice and improving the quality of life for individuals and families affected by neuromuscular disorders.

Dr. Maryam Oskoui, senior scientist in the Child Health and Human Development Program, received the Healthcare Partner of the Year Award from Muscular Dystrophy Canada.
Dr. Maryam Oskoui, senior scientist in the Child Health and Human Development Program, received the Healthcare Partner of the Year Award from Muscular Dystrophy Canada.

"I am deeply honoured to receive the Healthcare Partner of the Year Award from Muscular Dystrophy Canada—an organization whose vision, leadership, and engagement have truly transformed the lives of individuals living with neuromuscular disorders in Canada. As a clinician-scientist, this meaningful partnership advances research, strengthens standards of care, and translates knowledge into real-world impact," said Dr. Oskoui.

Dr. Oskoui is widely recognized for her leadership in spinal muscular atrophy (SMA) clinical care, newborn screening, practice guidelines, clinical trials and rare disease initiatives—areas that continue to shape neuromuscular care nationally and internationally.

Congratulations to Dr. Oskoui on this well-deserved honour.

Related news

Genetic causes of cerebral palsy uncovered through whole-genome sequencing

Significant funding to maximize access and drive excellence in clinical trials in Quebec and Canada